Cell Cycle Progression and Proliferation Despite 4BP-1 Dephosphorylation

REFERENCES

• Beretta, L., A.-C. Gingras, Y. V. Svitkin, M. N. Hall, and J. Sonenberg 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658–664.
   PubMed Web of Science ®Google Scholar
• Blackshear, P. J., D. J. Stumpo, E. Carballo, and J. Lawrence 1997. Disruption of the gene encoding the mitogen-regulated translational modulator PHAS-I in mice. J. Biol. Chem. 272:31510–31514.
   PubMedGoogle Scholar
• Blommaart, E. F., J. J. Luiken, P. J. Blommaart, G. M. van Woerkom, and J. Meijer 1995. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270:2320–2326.
   PubMed Web of Science ®Google Scholar
• Brown, E., T. Albers, T. Shin, K. Ichikawa, C. Keith, W. Lane, and J. Schreiber 1994. A mammalian protein targeted by G1-arresting rapamycin complex. Nature (London) 369:756–758.
   PubMed Web of Science ®Google Scholar
• Brown, E. J., P. A. Beal, C. T. Keith, J. Chen, T. B. Shin, and J. Schreiber 1995. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature (London) 377:441–446.
   PubMed Web of Science ®Google Scholar
• Brown, E. J., and J. Schreiber 1996. A signaling pathway to translational control. Cell 86:517–520.
   PubMed Web of Science ®Google Scholar
• Brunn, G. J., C. C. Hudson, A. Sekulic, J. M. Williams, H. Hosoi, P. J. Houghton, J. C. Lawrence, and J. Abraham 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99–101.
   PubMed Web of Science ®Google Scholar
• Calvo, V., M. Wood, C. Gjertson, T. Vik, and J. Bierer 1994. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation. Eur. J. Immunol. 24:2664–2671.
   PubMedGoogle Scholar
• De Benedetti, A., B. Joshi, J. R. Graff, and J. Zimmer 1994. CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol. Cell. Differ. 2:347–371.
   Google Scholar
• De Benedetti, A., and J. Rhoads 1990. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. USA 87:8212–8216.
   PubMed Web of Science ®Google Scholar
• Feigenblum, D., and J. Schneider 1996. Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation. Mol. Cell. Biol. 16:5450–5457.
   PubMedGoogle Scholar
• Gautsch, T. A., J. C. Anthony, S. R. Kimball, G. L. Paul, D. K. Layman, and J. Jefferson 1998. Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise. Am. J. Physiol. 274:C406–C414.
   PubMedGoogle Scholar
• Graves, L. M., K. E. Bornfeldt, G. M. Argast, E. G. Krebs, X. Kong, T. A. Lin, and J. Lawrence 1995. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 92:7222–7226.
   PubMed Web of Science ®Google Scholar
• Haghighat, A., S. Mader, A. Pause, and J. Sonenberg 1995. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14:5701–5709.
   PubMed Web of Science ®Google Scholar
• Hara, K., K. Yonezawa, M. T. Kozlowski, T. Sugimoto, K. Andrabi, Q.-P. Weng, M. Kasuga, I. Nishimoto, and J. Avruch 1997. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272:26457–26463.
   PubMed Web of Science ®Google Scholar
• Hara, K., K. Yonezawa, Q. P. Weng, M. T. Kozlowski, C. Belham, and J. Avruch 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273:14484–14494.
   PubMed Web of Science ®Google Scholar
• Heitman, J., N. R. Movva, and J. Hall 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905–909.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and J. Reed 1996. Translational control of p27kip1 accumulation during the cell cycle. Science 271:1861–1864.
   PubMed Web of Science ®Google Scholar
• Jeffries, H. B., S. Fumagalli, P. B. Dennis, C. Reinhard, R. B. Pearson, and J. Thomas 1997. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70S6K. EMBO J. 16:3693–3704.
   PubMedGoogle Scholar
• Kimball, S. R., R. L. Horetsky, and J. Jefferson 1998. Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. Am. J. Physiol. 274:C221–C228.
   PubMedGoogle Scholar
• Kimball, S. R., C. V. Jurasinski, J. C. Lawrence, and J. Jefferson 1997. Insulin stimulates protein synthesis in skeletal muscle by enhancing the association of eIF-4E and eIF-4G. Am. J. Physiol. 272:C754–C759.
   PubMedGoogle Scholar
• Lazaris-Karatzas, A., K. S. Montine, and J. Sonenberg 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature (London) 345:544–547.
   PubMed Web of Science ®Google Scholar
• Lin, T.-A., X. Kong, T. A. J. Haystead, A. Pause, G. Belsham, N. Sonenberg, and J. Lawrence 1994. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266:653–656.
   PubMed Web of Science ®Google Scholar
• Lin, T.-A., X. Kong, A. R. Saltiel, P. J. Blackshear, and J. Lawrence 1995. Control of PHAS-I by insulin in 3T3-L1 adipocytes. J. Biol. Chem. 270:18531–18538.
   PubMedGoogle Scholar
• Luo, Y., S. O. Marx, H. Kiyokawa, A. Koff, J. Massagué, and J. Marks 1996. Rapamycin resistance tied to defective regulation of p27Kip1. Mol. Cell. Biol. 16:6744–6751.
   PubMed Web of Science ®Google Scholar
• Marcotrigiano, J., A.-C. Gingras, N. Sonenberg, and J. Burley 1997. Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89:951–961.
   PubMed Web of Science ®Google Scholar
• Marx, S. O., T. Jayaraman, L. O. Go, and J. Marks 1995. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ. Res. 76:412–417.
   PubMed Web of Science ®Google Scholar
• Mendez, R., M. G. Myers Jr., M. F. White, and J. Rhoads 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 16:2857–2864.
   PubMed Web of Science ®Google Scholar
• Morley, S. J., and J. McKendrick 1997. Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells. J. Biol. Chem. 272:17887–17893.
   PubMed Web of Science ®Google Scholar
• Norbury, C., and J. Nurse 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441–470.
   PubMed Web of Science ®Google Scholar
• Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. Lee, J. Massague, G. Crabtree, and J. Roberts 1994. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (London) 372:570–573.
   PubMed Web of Science ®Google Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and J. Rolfe 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Pause, A., G. J. Belsham, A.-C. Gingras, O. Donze, T.-A. Lin, J. C. Lawrence, and J. Sonenberg 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature (London) 371:762–767.
   PubMed Web of Science ®Google Scholar
• Pedersen, S., J. E. Celis, J. Nielsen, J. Christiansen, and J. Nielsen 1997. Distinct repression of translation by wortmannin and rapamycin. Eur. J. Biochem. 247:449–456.
   PubMedGoogle Scholar
• Polunovsky, V. A., I. B. Rosenwald, A. T. Tan, J. White, L. Chiang, N. Sonenberg, and J. Bitterman 1996. Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol. Cell. Biol. 16:6573–6581.
   PubMed Web of Science ®Google Scholar
• Rau, M., T. Ohlmann, S. J. Morley, and J. Pain 1996. A reevaluation of the cap binding protein, eIF4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate. J. Biol. Chem. 271:8983–8990.
   PubMedGoogle Scholar
• Redpath, N. T., E. J. Foulstone, and J. Proud 1996. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15:2291–2297.
   PubMedGoogle Scholar
• Richon, V. M., R. A. Rifkind, P. A. Marks 1994. Cell biology: a laboratory handbook, p. 213–217. Academic Press, Inc., New York, N.Y.
   Google Scholar
• Rosenwald, I. B. 1996. Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett. 102:113–123.
   PubMedGoogle Scholar
• Rosenwald, I. B., R. Kaspar, D. Rousseau, L. Gehrke, P. Leboulch, J. J. Chen, E. V. Schmidt, N. Sonenberg, and J. London 1995. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J. Biol. Chem. 270:21176–21180.
   PubMed Web of Science ®Google Scholar
• Rosenwald, I. B., A. Lazaris-Karatzas, N. Sonenberg, and J. Schmidt 1993. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13:7358–7363.
   PubMed Web of Science ®Google Scholar
• Rousseau, D., R. Daspar, I. Rosenwald, L. Gehrke, and J. Sonenberg 1996. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA 93:1065–1070.
   PubMed Web of Science ®Google Scholar
• Rousseau, D., A. C. Gingras, A. Pause, and J. Sonenberg 1996. The eIF-4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13:2415–2420.
   PubMedGoogle Scholar
• Sabatini, D. M., H. Erdjument-Bromage, M. Lui, P. Tempst, and J. Snyder 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35–43.
   PubMed Web of Science ®Google Scholar
• Schreiber, S. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283–287.
   PubMed Web of Science ®Google Scholar
• von Manteuffel, S. R., A.-C. Gingras, X.-F. Ming, N. Sonenberg, and J. Thomas 1996. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 93:4076–4080.
   PubMedGoogle Scholar
• Vries, R. G. J., A. Flynn, J. C. Patel, X. Wang, R. M. Denton, and J. Proud 1997. Heat shock increases the association of binding protein-1 with initiation factor 4E. J. Biol. Chem. 272:32779–32784.
   PubMedGoogle Scholar
• Wang, X., L. E. Campbell, C. M. Miller, and J. Proud 1998. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334:261–267.
   PubMed Web of Science ®Google Scholar
• Yan, R., W. Rychlik, D. Etchison, and J. Rhoads 1992. Amino acid sequence of the human protein synthesis initiation factor eIF-4γ. J. Biol. Chem. 267:23226–23231.
   PubMedGoogle Scholar